BPG is committed to discovery and dissemination of knowledge
Articles in Press
11/20/2026 10:56:06 AM | Browse: 16 | Download: 5
Publication Name World Journal of Gastroenterology
Manuscript ID 127223
DOI 10.3748/wjg.127223
Country China
Category Gastroenterology & Hepatology
Manuscript Type Review
Article Title Angiogenic remodeling during hepatocarcinogenesis: From chronic liver disease to hepatocellular carcinoma
Manuscript Source Unsolicited Manuscript
All Author List Hong-Lin Chen, Yu-Ting Zhang, Dong Yao, Li Miao, Lin-Yan Wang and Li Wu
Funding Agency and Grant Number
Funding Agency Grant Number
National Natural Science Foundation of China 82405041
Corresponding Author Li Wu, PhD, Professor, Department of Pharmacology, School of Pharmacy, Nanjing University of Chinese Medicine, No. 138 Xianlin Avenue, Qixia District, Nanjing 210023, Jiangsu Province, China. wuli@njucm.edu.cn
Key Words Chronic liver disease; Hepatocellular carcinoma; Vascular remodeling; Immunosuppression; Carcinogenesis
Core Tip First-line clinical drugs for hepatocellular carcinoma (HCC), such as Sorafenib and Lenvatinib, are antiangiogenic, typically given in advanced-stage cancer, whereas cirrhosis management still concentrates on antiviral therapy, hepatoprotection and complication control. We review continuous vascular evolution from chronic liver disease (CLD) to HCC, spanning sinusoidal remodeling to portal hypertension, pathological angiogenesis and the switch of hepatic blood supply, and separate human clinical, observational, animal-model and in vitro evidence. These changes promote carcinogenesis through multiple mechanisms. Targeting characteristic vascular lesions can provide effective therapy for preventing malignant transformation of CLD. We propose "vascular window period", candidate biomarkers and imaging criteria as hypotheses awaiting prospective validation.
Citation Chen HL, Zhang YT, Yao D, Miao L, Wang LY, Wu L. Angiogenic remodeling during hepatocarcinogenesis: From chronic liver disease to hepatocellular carcinoma. World J Gastroenterol 2026; In press
PDF 127223-in-press.pdf
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Copyright ©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com